SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Reports that CEO Jensen Huang had an affair with a woman alleged to be a Chinese intelligence asset, prompting an Nvidia board investigation, are driving concern about governance, possible exposure of company secrets, and Huangs future. Traders are split between fearing a prolonged overhang or leadership change and viewing the selloff as an overreaction because they see no change to Nvidias business fundamentals.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio said ANKTIVA plus BCG met the primary endpoint in the randomized QUILT-2.005 trial for BCG-naive bladder cancer, drawing attention to the potential for a broader indication. Traders are awaiting full results and a planned FDA filing, while some caution that the initial share-price reaction may be muted until detailed data are released.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics quarterly results and raised full-year outlook have focused attention on Briumvis commercial growth, with bullish traders pointing to the drugs momentum. The community is also watching for the upcoming subcutaneous Briumvi trial readout, while buyout and short-squeeze speculation competes with concerns that earnings expectations are already priced in.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BMNRs sharp decline alongside weakness in Ethereum and broader crypto has traders focused on its discounted value relative to its ETH treasury and whether share buybacks can support the stock as BitMine approaches its 5% ETH-ownership goal. Bulls view the treasury, staking income and buybacks as a long-term opportunity; bears argue that BMNR keeps underperforming ETH and question managements execution and Tom Lees bullish calls.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.11892236 USD and is down -3.62 over the last 24 hours. It is currently trading on 1894 active market(s) with $1,884,610,999.15 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs sharp decline amid a broader crypto sell-off has traders focused on whether it will fall below $1 and where support may form. Bearish posts call for further losses and criticize XRPs weak performance, while others are buying the dip and holding; political explanations circulate but remain speculative.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Speculation that investors may rotate from Nvidia into AMD amid reports of a board investigation into CEO Jensen Huangs relationship with an alleged Chinese intelligence asset is driving attention. Traders also point to AMDs strong data-center results and Oppenheimers upgrade, though some caution that broader semiconductor weakness could weigh on AMD and that the rebound may not last.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

Concern over DefenCaths post-TDAPA reimbursement is driving the discussion, after DaVitas preliminary comments suggested payments could decline through 2027 and raised doubts about the drugs adoption and revenue outlook. Bulls argue DaVitas estimates are uncertain and point to CMS reimbursement support and potential Medicare Advantage growth, while others remain skeptical of managements communication and the commercial economics.

Constellation Energy Corp. engages in the generation, supply, and marketing of clean electricity, and renewable energy products and solutions. The firm also offers wholesale energy, retail products and services. It operates under the following geographical segments: Mid-Atlantic, Midwest, New York, Electric Reliability Council of Texas (ERCOT), and Other Power Regions Segment. The company was founded in 1960 and is headquartered in Baltimore, MD.

Constellation Energy Corporation

Stronger-than-expected Q3 results and an increased full-year profit outlook are driving attention, with traders cheering the update and share gain. The upbeat reaction contrasts with lingering debate over capital spending and how quickly AI data-center power demand will translate into returns.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

Zura Bios Phase 2 hidradenitis suppurativa study missing its primary endpoint is being viewed by some traders as a favorable competitive read-through for MoonLakes sonelokimab, though the studies are not direct comparisons. Discussion also points to a recent analyst upgrade and the upcoming FDA decision on whether to accept MoonLakes BLA for review.

Akamai Technologies, Inc. is the cybersecurity and cloud computing company that powers and protects business online. The market security solutions, superior threat intelligence, and global operations team provide defense in depth to safeguard enterprise data and applications everywhere. The firm full-stack cloud computing solutions deliver performance and affordability on the world’s most distributed platform. The global enterprises trust Akamai to provide the industry reliability, scale, and expertise they need to grow their business with confidence. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

Akamais earnings update and stronger 2027 growth outlook are drawing attention, with traders pointing to accelerating cloud infrastructure and AI demand despite concerns about high capital spending. The proposed convertible-note offering has renewed debate over financing needs, though the shares are rising and some investors view managements outlook as encouraging.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
